Clinithink
Company

Last deal

Amount

Venture - Series Unknown

Stage

03.04.2024

Date

3

all rounds

date founded

Financing round

General

About Company
Clinithink helps healthcare decision-makers to better understand patient information.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2009

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Clinithink, a technology and artificial intelligence services company, uses its patented CLiX program to convert unstructured medical patient charts into structured data. This helps solve challenges in healthcare by improving understanding of patient populations, highlighting important phenotypes, and reducing denied claims for providers. Clinithink has offices in the UK and the US and has received funding from investors such as Merck and TT Capital Partners.
Legal Names

Legal name

Clinithink Ltd
Similar Companies
1000
Agamon

Agamon

Agamon is a healthcare AI platform that transforms clinical data into knowledge.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care, Artificial Intelligence, Machine Learning

Location

New York, NY, USA

total rounds

3

total raised

$4M
MYPL

MYPL

MyPL is a digital platform revolutionizing cancer treatment by optimizing clinical research and improving patient care efficiency.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

SaaS, Health Care, Medical Device

Location

Montigny-le-Bretonneux, France
DatStat

DatStat

DatStat provides data capture and protocol workflow software for health-related institutions, providers, and researchers.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care, Software, Clinical Trials

Location

Seattle, WA, USA
Droice Labs

Droice Labs

Droice Labs is an AI company that uses real-world clinical data to solve healthcare problems.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care, Artificial Intelligence, Machine Learning

Location

New York, NY, USA

total rounds

4

Financials

Funding Rounds
4
3

Number of Funding Rounds

Their latest funding was raised on 03.04.2024. Their latest investor Development Bank of Wales. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Development Bank of Wales

Development Bank of Wales

Development Bank of Wales is an independent company that provides commercial funding to Welsh SMEs.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Venture Capital, Finance

Location

Cardiff, UK

count Of Investments

263

count Of Exists

21
Merck Sharp & Dohme Sweden AB

Merck Sharp & Dohme Sweden AB

Merck is a biopharmaceutical company that develops and provides innovative medicines and vaccines to save and improve lives globally.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Kenilworth, NJ, USA

total rounds

2

total raised

$5.59M

count Of Investments

21

count Of Exists

4
TT Capital Partners

TT Capital Partners

TT Capital Partners is a venture capital firm specializing in healthcare and information technology sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Banking, Advice

Location

Bloomington, MN, USA

count Of Investments

16

count Of Exists

5
Development Bank of Wales

Development Bank of Wales

Development Bank of Wales is an independent company that provides commercial funding to Welsh SMEs.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Venture Capital, Finance

Location

Cardiff, UK

count Of Investments

263

count Of Exists

21
Co-Investors
Investors
4
4

Number of lead investors

4

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Series A, Venture - Series Unknown
Development Bank of Wales

Development Bank of Wales

Development Bank of Wales is an independent company that provides commercial funding to Welsh SMEs.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Venture Capital, Finance

Location

Cardiff, UK

count Of Investments

263

count Of Exists

21
Merck Sharp & Dohme Sweden AB

Merck Sharp & Dohme Sweden AB

Merck is a biopharmaceutical company that develops and provides innovative medicines and vaccines to save and improve lives globally.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Kenilworth, NJ, USA

total rounds

2

total raised

$5.59M

count Of Investments

21

count Of Exists

4
TT Capital Partners

TT Capital Partners

TT Capital Partners is a venture capital firm specializing in healthcare and information technology sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Banking, Advice

Location

Bloomington, MN, USA

count Of Investments

16

count Of Exists

5
Conor Green

Conor Green

Mr. Conor Green serves as Partner at TT Capital Partners. He served as Board Member at Icario and Revel Health. He is focused on sourcing and leading investments in healthcare services and healthcare information technology companies. he has served as Board Member & Strategic Advisor at ConsumerMedical .Over the past decade at the firm he has worked closely with numerous healthcare companies as an advisor and then an investor and board member. Prior to joining TripleTree, he served in a product strategy role at athenahealth, a publicly-traded provider of web-based software and services to physicians. Prior to that, he worked in M&A and strategy roles within Reed Elsevier, mostly at Elsevier, the company's science publishing division. He began his career at L.E.K. Consulting, where he completed engagements in the M&A advisory practice as well as a number of longer-term projects for healthcare IT and life sciences clients. He earned an A.B. degree in Politics from Princeton University and an M.B.A. from the Stanford Graduate School of Business.

current job

TT Capital Partners
TT Capital Partners

People

Founders
2
Peter Johnson
Peter Johnson

Peter Johnson

current job

Clinithink
Clinithink

organization founded

1

Peter Johnson

Chris Tackaberry
Chris Tackaberry

Chris Tackaberry

Clinithink Co-Founder and Chief Executive Officer, Dr. Chris Tackaberry, is a former physician with nine years of anesthesiology and intensive care experience in the UK. Chris left clinical practice in 2000 and combined the benefits of his medical expertise and MSc degree in Computer Science when he joined iSOFT, a UK-based healthcare software company operating in more than 35 countries. During his time at iSOFT, Chris served in several roles, including Head of Clinical R&D, Clinical Director (Chief Medical Officer) and finally Product Management Director, where he oversaw a portfolio of more than 30 products driving approximately $320M of total annual revenue. Leading a team of over 200 product managers, business analysts and designers, Chris was instrumental in establishing iSOFT as a major global vendor of healthcare systems. After leaving iSOFT, Chris built a successful consulting practice focused on technology strategy, product management and major systems implementation. His clients included Lion Television Inc, the UK Department of Health, Silver Lake Partners and Skype. His vision to add meaning to, and get knowledge from, unstructured clinical data provides the direction for Clinithink and its technology.

current job

Clinithink
Clinithink

organization founded

1

Chris Tackaberry

Employee Profiles
8
Marc A. Horowitz

Marc A. Horowitz

Business Development Executive

Martin Deleay

Martin Deleay

CFO

Carl Cresswell

Carl Cresswell

Chief Architect

Phil Davies

Phil Davies

CIO and COO

Chris Tackaberry

Chris Tackaberry

Co-Founder and Chief Executive Officer

Peter Johnson

Peter Johnson

R&D Director

Activity

Recent News
1